Butyrate and Its Effects on Colon Cancer
Author Information
Author(s): Hu Shien Dong, Tien Sy Dalal, Sushila R. Wu, Feng Bissonnette, Marc Kwon, John H. Chang, Eugene B. Chang
Primary Institution: The Martin Boyer Laboratories, Department of Medicine, University of Chicago
Hypothesis
The anti-cancer effects of the microbe-derived SCFA butyrate may be mediated in part via changes in miRNA expression.
Conclusion
Butyrate regulates p21 gene expression and inhibits colon cancer cell proliferation through modulation of miRNAs.
Supporting Evidence
- Butyrate treatment altered the expression of 44 miRNAs in HCT-116 cells.
- Members of the miR-106b family were decreased in butyrate-treated cells and increased in colon cancer tissues.
- Butyrate increased p21 protein expression, which was inhibited by a miR-106b mimic.
- Butyrate decreased HCT-116 cell proliferation, an effect reversed with the addition of the miR-106b mimic.
Takeaway
Butyrate, a substance made by gut bacteria, helps fight colon cancer by changing tiny molecules called miRNAs that control gene activity.
Methodology
The study involved miRNA microarray analysis, real-time PCR, and luciferase reporter assays on HCT-116 colon cancer cells treated with butyrate.
Limitations
The study primarily focused on one cell line and may not fully represent the complexity of colon cancer in humans.
Participant Demographics
Human colon cancer patients provided tissue samples for analysis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website